arrow_back Trending Legislation
Share share

Funding for Early Detection and Treatment of Uterine Fibroids and Gynecological Health.

This law authorizes federal grants to states to enhance early detection and intervention programs for uterine fibroids. Citizens, particularly those in vulnerable communities, will benefit from improved access to advanced screening procedures, patient support services, and public health education campaigns focused on gynecological health. The act also mandates research into disparities in pain management during surgical treatments.
Key points
Provides grants to states to fund early detection programs, including advanced gynecological imaging and payment for these procedures.
Prioritizes funding for states serving socially vulnerable populations with a higher risk of developing uterine fibroids.
Mandates research into evidence-based strategies for early detection and studies on disparities in pain control during surgical treatment.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2024
Print number: HR 8247
Sponsor: Rep. Brown, Shontel M. [D-OH-11]
Process start date: 2024-05-06
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Funding for Early Detection and Treatment of Uterine Fibroids and Gynecological Health.

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 8247.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-05-06.

What are the main provisions?

Key points include:

  • Provides grants to states to fund early detection programs, including advanced gynecological imaging and payment for these procedures.
  • Prioritizes funding for states serving socially vulnerable populations with a higher risk of developing uterine fibroids.
  • Mandates research into evidence-based strategies for early detection and studies on disparities in pain control during surgical treatment.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Brown, Shontel M. [D-OH-11].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

Analysis and Potential Impact of HR 8247

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health